This publication by the Trudel group describes the development of a non-invasive MS-based assay, called EasyM, which is used to assess minimal residual disease, a measure of depth of response to treatment, which has become an important parameter in assessing the...
Fill out the contact form and we’ll do our very best to assist you.
Webinar: Whisper is coming
[gotowebinar-reg key=”6274999032686040843″]
Thank you joining us on October 14th. When you register for you webinar you will also join our monthly newsletter. You can unsubscribe at any time.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
No Fields Found.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have successfully typed in your email, a link will be sent to your where you can access the different material you showed interest in.
